Home LiteratureArticle Details
PMID: 9820504 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 161 ·No. 10 ·1998-11-15 ·Pages 5313-20

Bronte V, Wang M, Overwijk WW, Surman DR, Pericle F, Rosenberg SA, Restifo NP

Abstract

Following an infection or immunization, a primary CD8+ T cell response generally rises then falls rapidly before giving rise to a "memory" response. When we immunized mice with recombinant viral immunogens optimized to enhance the lytic capability of CD8+ T cells, we measured a profound depression in Ag-specific effector function after early restimulation. Indeed, a "mirror image" cytolytic capability was observed: the most powerful immunogens, as measured by cytolytic capacity 6 days after immunization, elicited the weakest secondary immune response when evaluated following an additional 6 days after restimulation. To understand the mechanism of this suppression, we examined the fate of splenocytes immunized with a vaccinia virus encoding Ag and IL-2 then restimulated ex vivo. We found that these splenocytes underwent an apoptotic cell death, upon early restimulation, that was not dependent on the engagement of the FasR (CD95). Unlike previously described mechanisms of "propriocidal cell death" and "clonal exhaustion," the cell death we observed was not an inherent property of the CD8+ T cells but rather was due to a population of splenocytes that stained positive for both the Mac-1 and Gr-1 surface markers. Deletion of these cells in vitro or in vivo completely abrogated the observed suppression of cytolytic reactivity of Ag-specific CD8+ T cells. These observations could account for the apparent absence of Ag-specific immune responses after some current vaccination regimens employing powerful immunogens. Finally, our results may shed new light on a mechanism for the suppression of CD8+ T cell responses and its effect on vaccine efficacy and on immune memory.

MeSH Terms
Animals Apoptosis/immunology CD8-Positive T-Lymphocytes/immunology,pathology Cancer Vaccines/genetics,immunology Cell Communication/immunology Cell Membrane/immunology Cytotoxicity, Immunologic Female HeLa Cells Humans Immune Tolerance Immunization Immunization, Secondary Interleukin-2/genetics Lymphocyte Activation Lymphocyte Count Lymphocyte Depletion Macrophage-1 Antigen/immunology,physiology Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Inbred MRL lpr T-Lymphocyte Subsets/immunology T-Lymphocytes, Regulatory/immunology Vaccinia virus/genetics,immunology beta-Galactosidase/genetics
Chemicals
Cancer Vaccines Interleukin-2 Macrophage-1 Antigen beta-Galactosidase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Bronte V
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. vbronte@ux1.unipd.it
Wang M
Overwijk W W
Surman D R
Pericle F
Rosenberg S A
Restifo N P
References (46)
46 references, click to expand
  1. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.
    Nature. 1993 Apr 22;362(6422):758-61 PMID: 8469287
  2. Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency.
    J Virol. 1993 Oct;67(10):5754-65 PMID: 8371341
  3. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.
    J Immunol. 1993 Oct 15;151(8):3971-80 PMID: 7691936
  4. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins.
    J Immunol. 1993 Nov 15;151(10):5492-503 PMID: 8228241
  5. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.
    Science. 1994 Feb 25;263(5150):1139-43 PMID: 7509084
  6. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    J Exp Med. 1994 Jun 1;179(6):1933-43 PMID: 8195718
  7. In vitro and in vivo kinetics of recombinant vaccinia virus cancer-gene therapy.
    Surgery. 1994 Aug;116(2):183-8 PMID: 8047984
  8. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.
    Nature. 1995 Feb 2;373(6513):444-8 PMID: 7530337
  9. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.
    J Immunol. 1995 May 1;154(9):4685-92 PMID: 7722321
  10. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.
    J Immunol. 1995 May 15;154(10):5282-92 PMID: 7730632
  11. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
    Cell. 1995 Jun 16;81(6):935-46 PMID: 7540117
  12. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
    J Leukoc Biol. 1995 Jun;57(6):919-28 PMID: 7790775
  13. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice.
    Am J Pathol. 1995 Jul;147(1):79-91 PMID: 7604887
  14. Cell cycle analysis of apoptosis using flow cytometry.
    Methods Cell Biol. 1995;46:77-97 PMID: 7609661
  15. Fas and FasL in the homeostatic regulation of immune responses.
    Immunol Today. 1995 Dec;16(12):569-74 PMID: 8579749
  16. T cells commit suicide, but B cells are murdered!
    J Immunol. 1996 Apr 1;156(7):2352-6 PMID: 8786289
  17. Die and let live: eliminating dangerous lymphocytes.
    Cell. 1996 Mar 8;84(5):655-7 PMID: 8625402
  18. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer.
    Int J Cancer. 1996 Jul 29;67(3):333-8 PMID: 8707405
  19. Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.
    J Immunother Emphasis Tumor Immunol. 1995 Oct;18(3):139-46 PMID: 8770769
  20. Role of Fas-mediated cell death in the regulation of immune responses.
    Curr Opin Immunol. 1996 Jun;8(3):355-61 PMID: 8793992
  21. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions.
    J Virol. 1996 Nov;70(11):8199-203 PMID: 8892953
  22. Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory.
    J Cell Biochem. 1995 Oct;59(2):135-42 PMID: 8904307
  23. Mechanisms of tumor-induced immunosuppression: evidence for contact-dependent T cell suppression by monocytes.
    Mol Med. 1996 Nov;2(6):692-701 PMID: 8972484
  24. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Blood. 1997 Feb 15;89(4):1341-8 PMID: 9028957
  25. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.
    Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3183-8 PMID: 9096367
  26. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
    J Exp Med. 1997 Apr 7;185(7):1241-51 PMID: 9104811
  27. The CD95 system and the death of a lymphocyte.
    Semin Immunol. 1997 Feb;9(1):59-68 PMID: 9106308
  28. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response.
    J Exp Med. 1997 May 5;185(9):1629-39 PMID: 9151900
  29. Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigens.
    Methods. 1997 Jun;12(2):117-23 PMID: 9184376
  30. Pathways leading to cell death in T cells.
    Curr Opin Immunol. 1997 Jun;9(3):358-64 PMID: 9203409
  31. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection.
    Immunity. 1998 Feb;8(2):167-75 PMID: 9491998
  32. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.
    Nat Med. 1998 Mar;4(3):321-7 PMID: 9500606
  33. A new look at T cells.
    J Exp Med. 1998 May 4;187(9):1367-71 PMID: 9565629
  34. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    J Immunol. 1985 Sep;135(3):1644-51 PMID: 3160774
  35. Natural suppressor (NS) cells found in the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype.
    J Immunol. 1984 Jan;132(1):101-10 PMID: 6228575
  36. Mononuclear-cell infiltration in ovarian cancer. III. Suppressor-cell and ADCC activity of macrophages from ascitic and solid ovarian tumours.
    Br J Cancer. 1982 May;45(5):747-53 PMID: 6211187
  37. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
    Mol Cell Biol. 1985 Dec;5(12):3403-9 PMID: 3939316
  38. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses.
    Virology. 1987 Oct;160(2):336-45 PMID: 3310381
  39. Immunosuppressive factors in human cancer.
    Adv Cancer Res. 1993;60:247-67 PMID: 7678060
  40. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.
    Cell Immunol. 1992 Mar;140(1):197-205 PMID: 1371242
  41. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.
    Nature. 1991 Oct 31;353(6347):858-61 PMID: 1944559
  42. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.
    J Immunol. 1991 Jul 1;147(1):22-8 PMID: 1711076
  43. Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors.
    J Immunol. 1991 Apr 15;146(8):2737-46 PMID: 2016525
  44. Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes.
    J Virol. 1990 Sep;64(9):4076-83 PMID: 2143539
  45. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships.
    Annu Rev Immunol. 1984;2:219-37 PMID: 6152690
  46. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    J Immunol. 1988 Jul 15;141(2):699-708 PMID: 2968407
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1998-11-15
Pages
5313-20
Language
English
Region
United States
NLM ID
2985117R
PMCID
PMC2239007
Subset
IM
Grants
Intramural NIH HHS · Z01 BC010763-01 · United States
Intramural NIH HHS · Z99 CA999999 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com